NASD · Financial · Insurance Brokers · USA
Corvel Corp is a mid cap company (market value between $2 billion and $10 billion) in the Insurance Brokers industry.
CorVel delivers services that help control healthcare expenses for workers' compensation claims, auto insurance, and group health benefits. Using artificial intelligence and machine learning, the company manages care episodes and medical costs through bill review, provider networks, case management, pharmacy services, and related solutions. CorVel serves insurance carriers, third-party administrators, government agencies, and self-insured employers.
From its FY2026 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Corvel Corp stock.
Overvalued: intrinsic value $27.34 per share, market price $87.62, margin of safety -220.5% (as of 2026-11-17).
Book value at 2.50x, the multiple a 30.6% return on equity justifies, blended with earnings, values the shares at $27.34; the price of $87.62 is 221% above that value.
17 more funds hold it; the full list is part of the paid plan.
All 24 Insurance Brokers stocks
CRVL is overvalued (as of the 2026-11-17 close). Book value at 2.50x, the multiple a 30.6% return on equity justifies, blended with earnings, values the shares at $27.34; the price of $87.62 is 221% above that value.
$27.34 per share (as of the 2026-11-17 close), against a market price of $87.62. That is a margin of safety of -220.5%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.